Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01600040 · ClinicalTrials.gov registry record · NA
Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01600040: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01600040 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01600040, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Proton beam radiation therapy is known to spare surrounding normal tissues from radiation. Proton beam radiation delivers less radiation beyond the area of the target tissues. This may reduce side effects that patients would normally experience with standard (photon) radiation therapy which tends to unavoidably include more normal tissue along with tumor target tissue. In this research study, the investigators are looking to determine if proton beam radiation is effective in controlling your cancer growth. The investigators are also looking to see if proton beam radiation can reduce side effects when compared to standard radiation treatment (photon radiation).
Interventions
- RADIATION Proton radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-08 |
| Est. Completion | 2023-08-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01600040
The ClinicalTrials.gov registry entry for NCT01600040 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proton radiation therapy is the first listed.
NCT01600040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01600040 about?
NCT01600040 is a clinical study titled "Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix". Proton beam radiation therapy is known to spare surrounding normal tissues from radiation. Proton beam radiation delivers less radiation beyond the area of the target tissues. This may reduce side effects that patients would normally experience with standard (photon) radiation therapy which tends to...
What is the current status of trial NCT01600040?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2013-08. Estimated completion is 2023-08-10.
What interventions are being tested in trial NCT01600040?
The interventions under investigation include: Proton radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT01600040?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.